CAF‐derived exosomes transmitted Gremlin‐1 promotes cancer progression and decreases the sensitivity of hepatoma cells to sorafenib
- 31 May 2022
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 61 (8) , 764-775
Abstract
Hepatocellular carcinoma (HCC) is one of the most lethal malignancies worldwide because of metastasis. An increasing number of studies have reported that cancer‐associated fibroblasts (CAFs) have emerged as the largest component of the stroma and play a critical role in tumor‐promoting processes. However, the effects of CAFs on cancer progression and the sensitivity of hepatoma cells to sorafenib are not well characterized. Here, we identified the proteome of CAF‐derived exosomes, and unveiled that exosomal Gremlin‐1 derived from CAFs contributes to epithelial–mesenchymal transition (EMT) of hepatoma cells and the decrease of the sorafenib sensitivity through regulating Wnt/β‐catenin and BMP signaling pathways. Compared to control subjects, the level of plasma exosomal Gremlin‐1 was significantly increased in HCC patients. Further studies indicated that plasma exosomal Gremlin‐1 may predict sorafenib response in HCC patients. Collectively, our findings uncover CAFs‐derived Gremlin‐1‐rich exosomes promote EMT and decrease the sensitivity of hepatoma cells to sorafenib by Wnt/β‐catenin and BMP signaling.Keywords
Funding Information
- National Natural Science Foundation of China (81972286, 82172585, 81870449, 82170674)
This publication has 37 references indexed in Scilit:
- Sorafenib Down-regulates Expression of HTATIP2 to Promote Invasiveness and Metastasis of Orthotopic Hepatocellular Carcinoma Tumors in MiceGastroenterology, 2012
- Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDOCancer Letters, 2012
- Gremlin-1 Induces BMP-Independent Tumor Cell Proliferation, Migration, and InvasionPLOS ONE, 2012
- Accessories to the Crime: Functions of Cells Recruited to the Tumor MicroenvironmentCancer Cell, 2012
- Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2Blood, 2010
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistanceDrug Resistance Updates, 2010
- Rab27a and Rab27b control different steps of the exosome secretion pathwayNature Cell Biology, 2009
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Prognosis of hepatocellular carcinomaHepatology, 2005
- PDGF β-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complexCell, 1990